Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Kaneo Satoh"'
Autor:
Chao Fang, Bo Ning, Ahmed Bilal Waqar, Manabu Niimi, Shen Li, Kaneo Satoh, Masashi Shiomi, Ting Ye, Sijun Dong, Jianglin Fan
Publikováno v:
PLoS ONE, Vol 9, Iss 10, p e110977 (2014)
Bisphenol A (BPA) is an environmental endocrine disrupter. Excess exposure to BPA may increase susceptibility to many metabolic disorders, but it is unclear whether BPA exposure has any adverse effects on the development of atherosclerosis. To determ
Externí odkaz:
https://doaj.org/article/310021edaf004344bbf4ebad0868fb41
Autor:
Makoto Osada, Kaneo Satoh, Yukio Ozaki, Shogo Tamura, Tomoyuki Sasaki, Katsue Suzuki-Inoue, Nagaharu Tsukiji, Toshiaki Shirai
Publikováno v:
Blood. 127:1701-1710
Megakaryopoiesis is the hierarchical differentiation of hematopoietic stem cells into megakaryocytes. Differentiating megakaryocytes undergo maturation characterized by endomitosis and produce numerous platelets through proplatelet formation. C-type
Autor:
Nagaharu Tsukiji, Katsue Suzuki-Inoue, Chihiro Mochizuki, Norihiko Umetani, Saito Tamio, Makoto Osada, Tomoyuki Sasaki, Kojima Soichi, Toshiaki Shirai, Osamu Inoue, Kaneo Satoh, Hideyuki Shinmori, Yukio Ozaki
Publikováno v:
Blood advances. 2(17)
The platelet activation receptor C-type lectin-like receptor 2 (CLEC-2) interacts with podoplanin on the surface of certain types of tumor cells, and this interaction facilitates tumor metastasis. CLEC-2 is also involved in thrombus formation and its
Autor:
Chao Fang, Shen Li, Ahmed Bilal Waqar, Ting Ye, Kaneo Satoh, Masashi Shiomi, Jianglin Fan, Sijun Dong, Bo Ning, Manabu Niimi
Publikováno v:
Journal of Applied Toxicology. 35:1058-1070
Bisphenol A (BPA) is an artificial environmental endocrine disrupter. Excess exposure to BPA may induce many disorders in the metabolism and cardiovascular system. However, the underlying toxicological mechanisms remain largely unknown. In this study
Autor:
Toshiaki Shirai, Jiro Ichikawa, Shogo Tamura, Kaneo Satoh, Tomoyuki Sasaki, Katsue Suzuki-Inoue, Shimon Otake, Nagaharu Tsukiji, Makoto Osada, Yukio Ozaki
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 16(5)
Essentials We generated recombinant rhodocytin that could aggregate platelets via CLEC-2. Recombinant wild-type rhodocytin formed heterooctamer with four α- and β-subunits. Asp 4 in α-subunit of rhodocytin was required for binding to CLEC-2. Inhib
Autor:
Koji Hashimoto, Hideyuki Yoshioka, Toru Horikoshi, Yoshihisa Nishiyama, Hiroyuki Kinouchi, Kaneo Satoh, Kazuya Kanemaru, Yukio Ozaki, Mitsuto Hanihara
Publikováno v:
Journal of Stroke and Cerebrovascular Diseases. 22:1196-1200
In-stent thrombosis (IST) after carotid artery stenting (CAS) is a rare but potentially devastating complication. We present a case of early IST after CAS despite sufficient antiplatelet therapy in a patient with bladder cancer. A 77-year-old man und
Autor:
Kaneo Satoh1 (AUTHOR), Toshiya Hirayama2 (AUTHOR), Katsuhiro Takano1 (AUTHOR), Katsue Suzuki-Inoue1 (AUTHOR), Tadashi Sato3 (AUTHOR), Masato Ohta1 (AUTHOR), Junko Nakagomi1 (AUTHOR), Yukio Ozaki1 (AUTHOR) yozaki@yamanashi.ac.jp
Publikováno v:
Thrombosis Journal. 2013, Vol. 11 Issue 1, p23-30. 8p. 2 Black and White Photographs, 1 Chart, 3 Graphs.
Publikováno v:
Clinical and Applied Thrombosis/Hemostasis. 20:629-636
It is implicated that diabetic patients are more resistant to aspirin therapy than patients with other diseases or healthy individuals. We evaluated the inhibitory effects of aspirin on aggregation and the cyclooxygenase activity of platelets of 10 p
Autor:
Kaneo Satoh, Kazuya Kanemaru, Masato Ohta, Shigemi Yoda, Osamu Inoue, Hiroyuki Kinouchi, Isao Fukasawa, Yukio Kimura, Yukio Ozaki
Publikováno v:
Thrombosis Research. 130:616-621
Introduction Cilostazol has been shown to be effective for prevention and treatment of cerebral infarction. However, there appears to be no widely accepted method appropriate for monitoring cilostazol. We attempted to establish an assay system for ci
Autor:
Katsue Suzuki-Inoue, Shogo Tamura, Osamu Inoue, Yukio Ozaki, Toshiaki Shirai, Hitomi Sato‐Uchida, Hiroshi Endo, Makoto Osada, Nagaharu Tsukiji, Tomoyuki Sasaki, Kaneo Satoh, Hideki Fujii
Publikováno v:
Journal of thrombosis and haemostasis : JTH. 15(3)
Essentials The role of C-type lectin-like receptor-2 (CLEC-2) in cancer progression is unclear. CLEC-2-depleted mouse model is generated by using a rat anti-mouse CLEC-2 monoclonal antibody. CLEC-2 depletion inhibits hematogenous tumor metastasis of